Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Karuna Therapeutics, Inc. | Chief Commercial Officer | Common Stock | 0 | $0 | $330.00 | Mar 18, 2024 | Direct |
Karuna Therapeutics, Inc. | Chief Commercial Officer | Restricted Stock Units | 0 | $0 | $330.00 | Mar 18, 2024 | Direct |
BioXcel Therapeutics, Inc. | Chief Commercial Officer | Stock Option (Right to Buy) | 40K | Aug 16, 2021 | Direct | ||
Karuna Therapeutics, Inc. | Chief Commercial Officer | Option (right to buy) | 0 | Mar 18, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
KRTX | Karuna Therapeutics, Inc. | Mar 18, 2024 | 4 | -$12.1M | 4 | Mar 18, 2024 | Chief Commercial Officer |
KRTX | Karuna Therapeutics, Inc. | Feb 13, 2024 | 1 | $0 | 4 | Feb 15, 2024 | Chief Commercial Officer |
KRTX | Karuna Therapeutics, Inc. | Dec 28, 2023 | 1 | -$1.21M | 4 | Dec 29, 2023 | Chief Commercial Officer |
KRTX | Karuna Therapeutics, Inc. | Feb 6, 2023 | 2 | $0 | 4 | Feb 7, 2023 | Chief Commercial Officer |
KRTX | Karuna Therapeutics, Inc. | Feb 6, 2023 | 0 | $0 | 3 | Feb 7, 2023 | Chief Commercial Officer |
BTAI | BioXcel Therapeutics, Inc. | Aug 16, 2021 | 1 | $0 | 4 | Aug 18, 2021 | Chief Commercial Officer |